• Co-Diagnostics launched an integrated cloud and mobile infrastructure in India to support clinical studies for its point-of-care tuberculosis test.
• Deployment adds localized, secure data storage designed to meet Indian privacy and cybersecurity requirements.
• Mobile analysis enables decentralized testing without internet access, with results synchronized to the cloud when connectivity returns.
• Architecture is positioned to support broader rollout of the Co-Dx PCR platform in India, with replication planned for Saudi Arabia and South Africa.
• Program is partly funded by the Gates Foundation, with samples processed on the PCR Pro instrument and analyzed on mobile devices.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Co-Diagnostics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202609030900PR_NEWS_USPR_____LA39800) on September 03, 2026, and is solely responsible for the information contained therein.